Gujarat Cancer And Research Institute-GCARI has published Tender 2023-25 For Purchase Of Anticancer Drugs- Cap. Acalabrutinib 100Mg,Cap. Atra 10Mg,Cap. Cyclosporine 100Mg,Cap. Cyclosporine 50Mg,Cap. Hydroxy Urea 500Mg,Cap. Midostaurin 25Mg,Cap. Procarbazine 50Mg,Cap. Tacrolimus 1Mg,Cap. Tegafur 100Mg + Uracil 22. Submission Date for this Tender is 03-08-2023. Medicine Tenders in Asarwa Gujarat. Bidders can get complete Tender details and download the document.
| Sr No | CorrigendumDate | Corrignedum | CorrigendumType | NewSubmissionDate |
| 1 | 18-Jul-2023 | 24-07-2023 | ||
| 2 | 20-Jul-2023 | 03-08-2023 |
| Sl. No. | Item Title | Std |
| 1 | Cap. Acalabrutinib 100mg | IP |
| 2 | Cap. ATRA 10mg | USP |
| 3 | Cap. Cyclosporine 100mg | IP |
| 4 | Cap. Cyclosporine 50mg | IP |
| 5 | Cap. Hydroxy Urea 500mg | USP |
| 6 | Cap. Midostaurin 25mg | IP |
| 7 | Cap. Procarbazine 50mg | IP |
| 8 | Cap. Tacrolimus 1mg | IP |
| 9 | Cap. Tegafur 100mg + Uracil 224mg | IP |
| 10 | Cap. Thalidomide 100mg | USP |
| 11 | Cap. Thalidomide 50mg | IP |
| 12 | Syp. Cyclosporine 100mg/ml - 50ml | USP |
| 13 | Ondansetron Oral Strip - 4mg | IP |
| 14 | Ondansetron Oral Strip - 8mg | IP |
| 15 | Tab. 6-Mercaptopurine 50mg | IP |
| 16 | Tab. Abemaciclib 150mg | - |
| 17 | Tab. Alpelisib 150mg | - |
| 18 | Tab. Alpelisib 200mg | - |
| 19 | Tab. Alpelisib 250mg | - |
| 20 | Tab. Anastrozole 1mg | IP |
| 21 | Tab. Bicalutamide 50mg | IP |
| 22 | Tab. Bosutinib 100mg | IP |
| 23 | Tab. Bosutinib 400mg | IP |
| 24 | Tab. Cabozantinib 20mg | - |
| 25 | Tab. Capecitabine DT 500mg | IP |
| 26 | Tab. Capecitabine DT 1000mg | IP |
| 27 | Tab. Chlorambucil 5mg | IP |
| 28 | Tab. Cyclophosphamide 50mg | IP |
| 29 | Tab. Eltrombopeg Olamine 25mg | - |
| 30 | Tab. Eltrombopeg Olamine 50mg | - |
| 31 | Tab. Everolimus 10mg | IP |
| 32 | Tab. Everolimus 5mg | EP |
| 33 | Tab. Leucovorin Calcium 15mg | IP |
| 34 | Tab. Megestrol Acetate 40mg | IP |
| 35 | Tab. Mycophenolate 500mg | IP |
| 36 | Tab. Netupitant 300mg + Palonosetron 0.5mg | IP |
| 37 | Tab. Olaparib 150mg | - |
| 38 | Tab. Pomalidomide 4mg | IP |
| 39 | Tab. Regorafenib 40mg | - |
| 40 | Tab. Rucaparib 300mg | IP |
| 41 | Tab. Ruxolitinib 20mg | - |
| 42 | Tab. Ruxolitinib 5mg | - |
| 43 | Tab. Ruxolitiniib 15mg | - |
| 44 | Tab. Sorafenib Tablets 200mg | IP |
| 45 | Tab. Tamoxifen Citrate 10mg | IP |
| 46 | Tab. Tamoxifen Citrate 20mg | IP |
| 47 | Inj. Arsenic Trioxide 10mg | IP |
| 48 | Inj. Azacitidine 50mg | IP |
| 49 | Inj. Bendamustine 45mg | IP |
| 50 | Inj. Bleomycin 15mg | IP |
| 51 | Inj. Busulfan 60mg/10ml | IP |
| 52 | Inj. Cabazitaxel 60mg/1.5ml | IP |
| 53 | Inj. Carmustine 100mg | USP |
| 54 | Inj. Cetuximab 100mg | IP |
| 55 | Inj. Cidofovir 375mg/5ml | IP |
| 56 | Inj. Cladribine 10mg | USP |
| 57 | Inj. Cyclophosphamide 1GM | IP |
| 58 | Inj. Cyclophosphamide 200mg | IP |
| 59 | Inj. Cyclophosphamide 500mg | IP |
| 60 | Inj. Dacarbazine 200mg | USP |
| 61 | Inj. Dacarbazine 500mg | USP |
| 62 | Inj. Dactinomycin 0.5mg | USP |
| 63 | Inj. Daunorubicin 20mg | IP |
| 64 | Inj. Decitabine 50mg | IP |
| 65 | Inj. Docetaxel Lipid Suspension 20mg | IP |
| 66 | Inj. Docetaxel Lipid Suspension 80mg | IP |
| 67 | Inj. Eribulin 1mg | IP |
| 68 | Inj. Erythropoietin 40,000 IU.PFS | IP |
| 69 | Inj. Fludarabine 50mg | USP |
| 70 | Inj. Fluro-Uracil 250mg/5ml I/V use | IP |
| 71 | Inj. Fluro-Uracil 500mg/10ml I/V use. | IP |
| 72 | Inj. Fos Aprepitant 150mg | IP |
| 73 | Inj. Human Normal Immunoglobulin 5gm/100ml | IP |
| 74 | Inj. Human Normal Immunoglobulin G 10gm | IP |
| 75 | Inj. Idarubicin 5mg | IP |
| 76 | Inj. Inotuzumab 1mg | - |
| 77 | Inj. Iplimumab 50mg/2ml | - |
| 78 | Inj. Leucovorin Calcium 50mg | IP |
| 79 | Inj. Leucovorin Calcium 15mg/2ml | IP |
| 80 | Inj. Melphalan 50mg | IP |
| 81 | Inj. Mesna 200mg/2ml | BP |
| 82 | Inj. Mitomycin 10mg | USP |
| 83 | Inj. Mitomycin 2mg | USP |
| 84 | Inj. Mitoxantrone20mg | USP |
| 85 | Inj. Nano Particle Albumin Bound Paclitaxel For Injectable Suspension 100mg | IP |
| 86 | Inj. Nimotuzumab 200mg | IP |
| 87 | Inj. Octreotide Injecton 100mcg | IP |
| 88 | Inj. Octreotide Lar 20mg | USP |
| 89 | Inj. Octreotide Lar 30mg | USP |
| 90 | Inj. Panitumumab 100mg | - |
| 91 | Inj. Pertuzumab 1200mg + Trastuzumab 600mg | - |
| 92 | Inj. Pertuzumab 600mg + Trastuzumab 600mg | - |
| 93 | Inj. Plerixafor 24mg | - |
| 94 | Inj. Rasburicase 1.5mg | USP |
| 95 | Inj. Romiplostim 250mcg | IP |
| 96 | Inj. Romiplostim 125mg | IP |
| 97 | Inj. Thiotepa 15mg | IP |
| 98 | Inj. Topotecan 2.5mg/2.5ml | IP |
| 99 | Inj. Triosulphan 5mg | - |
| 100 | Inj. Triptorelin Pamoate 11.25mg | - |
| 101 | Inj. Triptorelin Pamoate 3.75mg | - |
| 102 | Inj. Vinblastine Sulphate 10mg | IP |
| 103 | Inj. Vincristine Sulphate 1mg/1ml | USP |
| 104 | Inj. Vinorelbine50mg/5ml | IP |
| 105 | Inj. Zoledronic Acid 4mg | IP |
Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy
For Tender Information Services Visit : TenderDetail
